Rani Therapeutics Holdings Inc

Rani Therapeutics Soars with $60.3M Capital Raise and $1.09B Chugai Licensing Deal

Rani Therapeutics Holdings Inc has seen a significant surge in its market value, from $0.471 to over $18 million, following a $60.3 million private placement and a $1.09 billion licensing agreement with Chugai Pharmaceutical Co., positioning the com…

18/10/2025, 06:40

4 minutes to read

Rani Therapeutics Announces $3M Offering and Breakthrough Oral Biologics Research at ENDO 2025

Rani Therapeutics Holdings Inc. has announced key developments, including a $3 million registered direct offering and a late-breaking presentation at ENDO 2025, showcasing its innovative oral biologics delivery system, RaniPill.

16/07/2025, 01:16

2 minutes to read

Rani Therapeutics’ Preclinical Success with Oral Semaglutide Highlights Biotech Innovation Amid Market Volatility

Rani Therapeutics Holdings Inc’s recent preclinical success with oral semaglutide delivery has sparked excitement, but its stock price volatility and complex valuation landscape raise concerns about the company’s financial stability.

13/05/2025, 22:19

3 minutes to read